Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TRBN

Trubion Pharmaceuticals (MM) (TRBN)

Trubion Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRBN
DateTimeSourceHeadlineSymbolCompany
08/07/20084:06PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Quarterly Report (10-Q)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
07/31/20084:00PMPR Newswire (US)Trubion Pharmaceuticals Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference CallNASDAQ:TRBNTrubion Pharmaceuticals (MM)
07/30/20084:00PMPR Newswire (US)Trubion Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals ConferenceNASDAQ:TRBNTrubion Pharmaceuticals (MM)
07/29/20084:35PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Current report filing (8-K)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
06/19/20084:04PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Current report filing (8-K)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
06/19/20084:00PMPR Newswire (US)Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth CollaborationNASDAQ:TRBNTrubion Pharmaceuticals (MM)
06/16/20084:00PMPR Newswire (US)Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of RheuNASDAQ:TRBNTrubion Pharmaceuticals (MM)
06/05/20084:06PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
06/04/20084:00PMPR Newswire (US)Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology ConferenceNASDAQ:TRBNTrubion Pharmaceuticals (MM)
06/02/20085:00PMPR Newswire (US)Trubion Announces Presentation of Positive TRU-016 Data at ASCONASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/29/20082:13PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/29/20082:12PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/29/20082:11PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/29/20082:10PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/29/20082:09PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/29/20082:08PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/29/20082:07PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/12/20086:02AMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Current report filing (8-K)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/08/20084:13PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Quarterly Report (10-Q)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/08/20084:00PMPR Newswire (US)Trubion Pharmaceuticals Inc. Reports First Quarter 2008 ResultsNASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/07/20084:00PMPR Newswire (US)Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid ArthritisNASDAQ:TRBNTrubion Pharmaceuticals (MM)
05/01/20085:00PMPR Newswire (US)Trubion Pharmaceuticals Provides Announcement Dates for First-Quarter Earnings Conference CallNASDAQ:TRBNTrubion Pharmaceuticals (MM)
04/24/20085:00PMPR Newswire (US)Trubion Announces Presentations at April/May Investor ConferencesNASDAQ:TRBNTrubion Pharmaceuticals (MM)
04/21/20084:10PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
04/21/20085:00PMPR Newswire (US)Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid ArthritisNASDAQ:TRBNTrubion Pharmaceuticals (MM)
04/08/20085:25PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Amended Current report filing (8-K/A)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
03/27/20084:58PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Current report filing (8-K)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
03/27/20084:00PMPR Newswire (US)Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product PipNASDAQ:TRBNTrubion Pharmaceuticals (MM)
03/25/20085:23PMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Current report filing (8-K)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
03/24/200811:15AMEdgar (US Regulatory)Trubion Pharmaceuticals, Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:TRBNTrubion Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:TRBN